TRD205 clinical trials
How each study uses TRD205 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the TRD205 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2025 (3)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses TRD205 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)RecruitingPhase 2Beijing Tide Pharmaceutical Co., LtdNCT07543796Written as TRD205 Tablets, oral; 400 mg initial dose, then 200 mg q12h for 3 doses; total 4 doses
- To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative NeuralgiaEnrolling by invitationPhase 2Beijing Tide Pharmaceutical Co., LtdNCT07123402Written as TRD205 tablets
- To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip ArthroplastyNot yet recruitingPhase 2Beijing Tide Pharmaceutical Co., LtdNCT07121101Written as TRD205 tablets
- To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic SurgeryNot yet recruitingPhase 1Beijing Tide Pharmaceutical Co., LtdNCT07121023Written as TRD205 tablets
- Single and Multiple Ascending Doses and Food Effect Study of TRD205 in Healthy VolunteersCompletedPhase 1Beijing Tide Pharmaceutical Co., LtdNCT07123428Written as TRD205